Biosimilar competition: Early learning.

Frank, Richard G; Shahzad, Mahnum; Kesselheim, Aaron S; Feldman, William

Frank, Richard G; Shahzad, Mahnum; Kesselheim, Aaron S; Feldman, William.

Afiliação

Frank RG; The Brookings Institution, Washington, District of Columbia, USA.
Shahzad M; Harvard University, Cambridge, Massachusetts, USA.
Kesselheim AS; Program on Regulation, Therapeutics, and Law (PORTAL), Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA.
Feldman W; Program on Regulation, Therapeutics, and Law (PORTAL), Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA.

Health Econ ; 31(4): 647-663, 2022 04.

Article em En | MEDLINE | ID: mdl-35023225

Assuntos

Medicamentos Biossimilares; Custos e Análise de Custo; Custos de Medicamentos; Indústria Farmacêutica; Competição Econômica; Humanos

Palavras-chave

biosimilar; competition; prices

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google